Kurs
+1,45%
Likviditet
0,65 MSEK
Kalender
Est. tid* | ||
2026-02-10 | 08:30 | Bokslutskommuniké 2025 |
2025-10-24 | 08:30 | Kvartalsrapport 2025-Q3 |
2025-07-17 | 08:30 | Kvartalsrapport 2025-Q2 |
2025-05-15 | N/A | X-dag ordinarie utdelning PREV B 4.75 SEK |
2025-05-14 | N/A | Årsstämma |
2025-05-06 | 08:30 | Kvartalsrapport 2025-Q1 |
2025-02-11 | - | Bokslutskommuniké 2024 |
2024-10-25 | - | Kvartalsrapport 2024-Q3 |
2024-07-19 | - | Kvartalsrapport 2024-Q2 |
2024-05-16 | - | X-dag ordinarie utdelning PREV B 4.75 SEK |
2024-05-15 | - | Årsstämma |
2024-05-07 | - | Kvartalsrapport 2024-Q1 |
2024-02-14 | - | Bokslutskommuniké 2023 |
2023-10-26 | - | Kvartalsrapport 2023-Q3 |
2023-07-18 | - | Kvartalsrapport 2023-Q2 |
2023-05-12 | - | X-dag ordinarie utdelning PREV B 4.50 SEK |
2023-05-11 | - | Årsstämma |
2023-04-27 | - | Kvartalsrapport 2023-Q1 |
2023-02-09 | - | Bokslutskommuniké 2022 |
2022-10-27 | - | Kvartalsrapport 2022-Q3 |
2022-07-19 | - | Kvartalsrapport 2022-Q2 |
2022-05-19 | - | X-dag ordinarie utdelning PREV B 3.50 SEK |
2022-05-18 | - | Årsstämma |
2022-04-28 | - | Kvartalsrapport 2022-Q1 |
2022-02-11 | - | Bokslutskommuniké 2021 |
2021-10-28 | - | Kvartalsrapport 2021-Q3 |
2021-07-21 | - | Kvartalsrapport 2021-Q2 |
2021-05-12 | - | X-dag ordinarie utdelning PREV B 2.00 SEK |
2021-05-11 | - | Årsstämma |
2021-05-06 | - | Kvartalsrapport 2021-Q1 |
2021-02-11 | - | Bokslutskommuniké 2020 |
2020-11-24 | - | Extra Bolagsstämma 2020 |
2020-10-23 | - | Kvartalsrapport 2020-Q3 |
2020-07-15 | - | Kvartalsrapport 2020-Q2 |
2020-05-15 | - | X-dag ordinarie utdelning PREV B 0.00 SEK |
2020-05-14 | - | Årsstämma |
2020-04-29 | - | Kvartalsrapport 2020-Q1 |
2020-02-12 | - | Bokslutskommuniké 2019 |
2019-10-24 | - | Kvartalsrapport 2019-Q3 |
2019-07-17 | - | Kvartalsrapport 2019-Q2 |
2019-05-15 | - | X-dag ordinarie utdelning PREV B 0.00 SEK |
2019-05-14 | - | Årsstämma |
2019-04-24 | - | Kvartalsrapport 2019-Q1 |
2019-02-13 | - | Bokslutskommuniké 2018 |
2018-10-24 | - | Kvartalsrapport 2018-Q3 |
2018-07-17 | - | Kvartalsrapport 2018-Q2 |
2018-05-17 | - | X-dag ordinarie utdelning PREV B 0.00 SEK |
2018-05-16 | - | Årsstämma |
2018-05-03 | - | Kvartalsrapport 2018-Q1 |
2018-02-08 | - | Bokslutskommuniké 2017 |
2017-10-25 | - | Kvartalsrapport 2017-Q3 |
2017-07-18 | - | Kvartalsrapport 2017-Q2 |
2017-05-10 | - | X-dag ordinarie utdelning PREV B 0.00 SEK |
2017-05-09 | - | Årsstämma |
2017-04-25 | - | Kvartalsrapport 2017-Q1 |
2017-02-09 | - | Bokslutskommuniké 2016 |
2016-10-27 | - | Kvartalsrapport 2016-Q3 |
2016-07-19 | - | Kvartalsrapport 2016-Q2 |
2016-04-26 | - | Kvartalsrapport 2016-Q1 |
2016-04-18 | - | X-dag ordinarie utdelning PREV B 0.00 SEK |
2016-04-14 | - | Årsstämma |
2016-02-10 | - | Bokslutskommuniké 2015 |
2015-10-28 | - | Kvartalsrapport 2015-Q3 |
2015-07-15 | - | Kvartalsrapport 2015-Q2 |
2015-04-29 | - | Kvartalsrapport 2015-Q1 |
2015-04-17 | - | X-dag ordinarie utdelning PREV B 0.00 SEK |
2015-04-16 | - | Årsstämma |
2015-02-10 | - | Bokslutskommuniké 2014 |
2014-10-29 | - | Kvartalsrapport 2014-Q3 |
2014-07-16 | - | Kvartalsrapport 2014-Q2 |
2014-04-29 | - | Kvartalsrapport 2014-Q1 |
2014-04-09 | - | X-dag ordinarie utdelning PREV B 0.00 SEK |
2014-04-08 | - | Årsstämma |
2014-02-11 | - | Bokslutskommuniké 2013 |
2013-10-29 | - | Kvartalsrapport 2013-Q3 |
2013-07-16 | - | Kvartalsrapport 2013-Q2 |
2013-04-30 | - | Kvartalsrapport 2013-Q1 |
2013-04-09 | - | X-dag ordinarie utdelning PREV B 0.30 SEK |
2013-04-08 | - | Årsstämma |
2013-02-08 | - | Bokslutskommuniké 2012 |
2012-10-26 | - | Kvartalsrapport 2012-Q3 |
2012-07-17 | - | Kvartalsrapport 2012-Q2 |
2012-04-25 | - | Kvartalsrapport 2012-Q1 |
2012-03-27 | - | X-dag ordinarie utdelning PREV B 0.30 SEK |
2012-03-26 | - | Årsstämma |
2012-02-03 | - | Bokslutskommuniké 2011 |
2011-10-21 | - | Kvartalsrapport 2011-Q3 |
2011-06-15 | - | Kvartalsrapport 2011-Q2 |
2011-04-29 | - | Kvartalsrapport 2011-Q1 |
2011-03-31 | - | X-dag ordinarie utdelning |
2011-03-30 | - | Årsstämma |
2011-02-04 | - | Bokslutskommuniké 2010 |
2010-10-22 | - | Kvartalsrapport 2010-Q3 |
2010-07-16 | - | Kvartalsrapport 2010-Q2 |
2010-04-30 | - | Kvartalsrapport 2010-Q1 |
2010-03-31 | - | X-dag ordinarie utdelning PREV B 0.00 SEK |
2010-03-30 | - | Årsstämma |
2010-02-05 | - | Bokslutskommuniké 2009 |
2009-10-23 | - | Kvartalsrapport 2009-Q3 |
2009-07-17 | - | Kvartalsrapport 2009-Q2 |
2009-04-28 | - | Kvartalsrapport 2009-Q1 |
2009-04-01 | - | X-dag ordinarie utdelning PREV B 1.50 SEK |
2009-03-31 | - | Årsstämma |
Beskrivning
Land | Sverige |
---|---|
Lista | Small Cap Stockholm |
Sektor | Tjänster |
Industri | IT-konsult & onlinetjänster |
BIOSENS®900 - an updated detection system for drugs and explosive substances from the Swedish company Biosensor Applications - will be introduced during the spring. The instrument has been developed, tested and certified in close cooperation with Prevas.
The BIOSENS®900 is a portable instrument that is used to detect traces of drugs and explosives. The analysis is used to confirm suspicions and make it easier to continue searching for prohibited substances. The system is used by customers all over the world, above all for checking goods, containers and luggage at border controls and customs filters.
"The system is distinguished by high user-friendliness, low frequency of false alarms and exceptional sensitivity in real-world environments outside the laboratory," says Magnus Nygren, Marketing Manager at Biosensor Applications. "The detection capacity can be adapted to the customer's needs, and we are constantly working to enable the identification of new substances."
The Biosens series has been on the market for more than 20 years, with the BIOSENS®900 representing the third generation of the instrument. Prevas has long supported Biosensor Applications with the management and further development of the system's software platform, and they were also commissioned to assist with the development and launch of the new instrument model.
"Prevas possesses in-depth knowledge of our products and systems, so the start-up phase for the development project was short," says Magnus Nygren. "They have been able to offer support in all the required areas of the project, including software, mechanics, electronics and EMC testing."
The BIOSENS®900 has been updated in several areas. The system is now battery-powered and the handling of consumables has been simplified. Its size and weight have been reduced by more than 30 percent, and the instrument has gained an entirely new platform for electronics and mechanics. The software platform has also been adapted to support new features and future-proof production.
"Our joint efforts have resulted in a very robust and secure system," says Patrik Åkerlind, Consultant Manager for Software and Embedded Systems at Prevas. "It has also been interesting and rewarding to work with a product that contributes to the authorities' ability to combat the trade in drugs and explosives, which has become a global societal problem."
Read more about the project with Biosensor Applications on the Prevas website.
For more information, contact
Patrik Åkerlind, Consulting Manager Software & Embedded Systems, Prevas AB
Mobil: +46 70 190 23 26, E-mail: patrik.akerlind@prevas.se
Magnus Nygren, Marketing Manager, Biosensor Applications AB
Mobil: +46 70 586 55 94, E-mail: magnus.Nygren@biosensor.se